Cumberland Pharmaceuticals Competitors and Similar CompaniesClear all

Cumberland Pharmaceuticals's competitors and similar companies include UCB.
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a company that focuses on the development and commercialization of prescription products for the hospital acute care and gastroenterology sectors.
UCB
UCB
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date
Founding Date
1999
Founding Date
1928
Type
Type
Public
Type
Public
Tags
Locations
Locations
Nashville, US HQ
Locations
Brussels, BE HQ
Melbourne, AU
Vienna, AT
Braine L'alleud, BE
Braine L'alleud, BE
Leuven, BE
São Paulo, BR
see more
Employees
Employees
91
Employees
9,052
Valuation ($)
Valuation ($)
17.6 m
Valuation ($)
34.3 b

Financial

Revenue (est.)
Revenue (est.)
$44.5m (FY, 2025)
Revenue (est.)
€7.4b (FY, 2025)
Cost of goods
Cost of goods
$6.7m (FY, 2025)
Cost of goods
€1.4b (FY, 2025)
Gross profit
Gross profit
$37.9m (FY, 2025)
Gross profit
€7.2b (FY, 2025)
Net income
Net income
($2.9m) (FY, 2025)
Net income
€1.6b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

UCB
HQ
Brussels, BE
Employees
9,052

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

View company